JPRN-UMIN000051193尚未招募Unknown
Aripiprazole dose reduction in stable schizophrenia - Aripiprazole dose reduction in stable schizophrenia
适应症
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1) Having a history of obvious harm to him/herself and/or others (2) Having significant physical or neurological illnesses (3) Having a diagnose of mental and behavioral disorders due to psychoactive substance use according to ICD-10 (4) Being pregnant or lactating (5) Having been judged as unable to provide informed consent by a person who explains the study (6) Being prohibited to receive reimbursement (in cases such as receiving public assistance and being prohibited from receiving reimbursement by the public assistance case worker) (7) Having been judged as unsuitable for the study for other reasons by the principal investigator
研究者
相似试验
已完成
不适用
Aripiprazole research over schizophrenia patients (both on first episode and recurrence) about its efficacy and influence on cognitive functioschizophreniaJPRN-UMIN000002076Kyoto University Hospital20
招募中
4 期
Treatment of Schizophrenia with Aripiprazole. A one year open-label study.Mental Health - SchizophreniaSchizophreniaACTRN12605000394640Associate Professor Krishna Vaddadi40
已完成
4 期
Aripiprazole for the Treatment of Schizophrenia With Co-Morbid Social AnxietySchizophreniaSchizoaffective DisorderSocial Anxiety DisorderNCT00177008University of Medicine and Dentistry of New Jersey18
已完成
2 期
Aripiprazole Treatment of Prodromal PatientsPsychosisSchizophreniaNCT00237874Yale University15
已完成
4 期
Brexpiprazole for the treatment of acute schizophrenia in the Japanese populatioschizophreniaJPRN-UMIN000032339Fujita Health University School of Medicine100